The Carlat Psychiatry Podcast podkast

ProLivRx: A New Approval in Depression

0:00
20:50
Do tyłu o 15 sekund
Do przodu o 15 sekund

We interview Linda Carpenter, lead investigator on the new FDA approved device for difficult-to-treat depression.

CME: Take the CME Post-Test for this Episode

Published On: 01/19/2026

Duration: 20 minutes, 49 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Więcej odcinków z kanału "The Carlat Psychiatry Podcast"